[Scleroderma].
Fujita
Y
Y
Department of Pediatrics, Nihon University School of Medicine.
D001323:Autoantibodies; D016207:Cytokines; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018799:Intercellular Adhesion Molecule-1; D016169:Lymphocyte Function-Associated Antigen-1; D008214:Lymphocytes / Q000276:immunology; D010396:Penicillamine / Q000627:therapeutic use; D011296:Prenatal Diagnosis; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000209:etiology / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use
D001323:Autoantibodies; D016207:Cytokines; D007166:Immunosuppressive Agents; D016169:Lymphocyte Function-Associated Antigen-1; D014665:Vasodilator Agents; D018799:Intercellular Adhesion Molecule-1; D010396:Penicillamine